Add to ORKGAbstract Background Botulinum toxin (BT) injection reduces lower esophageal sphincter pressure and alleviates symptoms in idiopathic achalasia (IA). Ethanolamine oleate (EO) has also been introduced for the treatment of IA. We compared the long-term effi cacy of BT and EO injections in the treatment of IA
Achalasia was a condition marked by peristaltic movement absent in lower esophageal sphincter and se...
Botulotokšina injekcija sfinkterī pacientiem ar ahālaziju tiek ieteikta kā alternatīva metode dilāta...
Endoscopic injection of botulinum toxin (BTX) has shown benefits for patients with diffuse esophagea...
The aim of all current forms of treatment of achalasia is to enable the patient to eat without disab...
Achalasia represents the absence of lower esopaheal sphincter relaxation and absence of normal peris...
Although a number of the therapeutic techniques are used for the treatment of achalasia, none of the...
Purpose Achalasia is a rare, but well-defined primary esophageal motor disorder. Classic therapeutic...
Background: Achalasia is an infrequent primary motility disorder of the esophagus. Because of uncer...
Copyright © 2015 JCBN2015This is an open access article distributed under the terms of theCreat ve C...
Background: Achalasia is a disorder of the esophagus. The lower esophageal sphincter fails to relax ...
Esophageal achalasia is a chronic and progressive motility disorder characterized by absence of esop...
Background: Achalasia is an infrequent primary motility disorder of the esophagus. Because of uncert...
Achalasia is a primary esophageal motor disorder of the esophagus that is characterized by the absen...
Achalasia is a disorder of esophageal motility, which is manifested by symptoms of dysphagia, belchi...
Background: Achalasia is an infrequent primary motility disorder of the esophagus. Because of uncert...
Achalasia was a condition marked by peristaltic movement absent in lower esophageal sphincter and se...
Botulotokšina injekcija sfinkterī pacientiem ar ahālaziju tiek ieteikta kā alternatīva metode dilāta...
Endoscopic injection of botulinum toxin (BTX) has shown benefits for patients with diffuse esophagea...
The aim of all current forms of treatment of achalasia is to enable the patient to eat without disab...
Achalasia represents the absence of lower esopaheal sphincter relaxation and absence of normal peris...
Although a number of the therapeutic techniques are used for the treatment of achalasia, none of the...
Purpose Achalasia is a rare, but well-defined primary esophageal motor disorder. Classic therapeutic...
Background: Achalasia is an infrequent primary motility disorder of the esophagus. Because of uncer...
Copyright © 2015 JCBN2015This is an open access article distributed under the terms of theCreat ve C...
Background: Achalasia is a disorder of the esophagus. The lower esophageal sphincter fails to relax ...
Esophageal achalasia is a chronic and progressive motility disorder characterized by absence of esop...
Background: Achalasia is an infrequent primary motility disorder of the esophagus. Because of uncert...
Achalasia is a primary esophageal motor disorder of the esophagus that is characterized by the absen...
Achalasia is a disorder of esophageal motility, which is manifested by symptoms of dysphagia, belchi...
Background: Achalasia is an infrequent primary motility disorder of the esophagus. Because of uncert...
Achalasia was a condition marked by peristaltic movement absent in lower esophageal sphincter and se...
Botulotokšina injekcija sfinkterī pacientiem ar ahālaziju tiek ieteikta kā alternatīva metode dilāta...
Endoscopic injection of botulinum toxin (BTX) has shown benefits for patients with diffuse esophagea...